Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olumiant (baricitinib)
Pharma
AbbVie's Rinvoq produces stellar results in alopecia study
Results from a phase 3 trial indicate that AbbVie's JAK inhibitor Rinvoq could take a prominent place in the treatment of alopecia areata.
Fraiser Kansteiner
,
Kevin Dunleavy
Aug 4, 2025 11:38am
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
Incyte wins injunction to block Sun's Leqselvi launch
Nov 4, 2024 10:01am
Lilly strikes Olumiant licensing deal with Egypt's Eva Pharma
Sep 4, 2024 10:49am
Sun Pharma snags FDA OK for alopecia areata drug Leqselvi
Jul 26, 2024 10:57am
Pfizer's Litfulo boasts an alopecia edge over Lilly's Olumiant
Jun 26, 2023 9:30am